Valdecoxib

• Description :

  Valdecoxib was removed from the Canadian, U.S., and E.U. markets in 2005 due to concerns about possible increased risk of heart attack and stroke.

• Stability :

  ≥ 2 years

• Purity :

  >98% (HPLC)

• Weight :

  314.36

• Molecular Formula :

  C16H14N2O3S

• Notes :

  Research use only, not for human use.

• Receptor :

  COX-2

• CAS Number :

  181695-72-7